Generic Pharmaceutical Association

Dec 03, 2018

Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Less than Half of 10% Commitment

Oct 01, 2018

CGPA Statement on Pharmaceutical Concessions in United States-Mexico-Canada Agreement

Sep 05, 2018

CGPA Statement on the Resumption of US-Canada Trade Talks

Apr 09, 2018

Peter Hardwick of Apotex Elected Chair of Canadian Generic Pharmaceutical Association

Dec 04, 2017

Biopharmaceutical Companies Prepare for Competition: New Report

Dec 04, 2017

Biopharmaceutical Companies Prepare for Competition: New Report

Nov 14, 2017

New Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Less than Half of 10% Commitment

Sep 12, 2017

AAM Biosimilars Council Releases 2017 Report on Patient Access to Biosimilars in the United States

Sep 11, 2017

Physician Groups Urge CMS to Adopt Unique Billing Codes for Biosimilar Reimbursement Policy

Jul 26, 2017

Global Biosimilar Market Expected to Reach USD 36 Billion by 2020